N-ethyl-N-[(Z)-1-[(Z)-[(Z)-2-fluoro-3-methylpent-2-enylidene]amino]prop-1-enyl]nonan-5-amine
C20H37FN2 — CID 142121293
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-ethyl-N-[(Z)-1-[(Z)-[(Z)-2-fluoro-3-methylpent-2-enylidene]amino]prop-1-enyl]nonan-5-amine
N-ethyl-N-[(Z)-1-[(Z)-[(Z)-2-fluoro-3-methylpent-2-enylidene]amino]prop-1-enyl]nonan-5-amine (PubChem CID 142121293) has the molecular formula C20H37FN2 and a molecular weight of 324.53 g/mol. Its IUPAC name is N-ethyl-N-[(Z)-1-[(Z)-[(Z)-2-fluoro-3-methylpent-2-enylidene]amino]prop-1-enyl]nonan-5-amine.
Molecular Properties
| Compound Name | N-ethyl-N-[(Z)-1-[(Z)-[(Z)-2-fluoro-3-methylpent-2-enylidene]amino]prop-1-enyl]nonan-5-amine |
|---|---|
| PubChem CID | 142121293 |
| Molecular Formula | C20H37FN2 |
| Molecular Weight | 324.53 g/mol |
| Exact Mass | 324.29 |
| IUPAC Name | N-ethyl-N-[(Z)-1-[(Z)-[(Z)-2-fluoro-3-methylpent-2-enylidene]amino]prop-1-enyl]nonan-5-amine |
| SMILES | C/C=C(\N=C/C(F)=C(\C)CC)N(CC)C(CCCC)CCCC |
| InChI | InChI=1S/C20H37FN2/c1-7-12-14-18(15-13-8-2)23(11-5)20(10-4)22-16-19(21)17(6)9-3/h10,16,18H,7-9,11-15H2,1-6H3/b19-17-,20-10+,22-16- |
| InChIKey | MMGGIXMWFXWXLB-HFKLQUFVSA-N |
| XLogP | 6.64 |
| TPSA | 15.60 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 2 |
| Rotatable Bonds | 12 |
| Heavy Atoms | 23 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 324.53 |
| LogP ≤ 5 | 6.64 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 2 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'imine_1', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 142121293 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.